Sana Biotechnology Inc expected to post a loss of 47  cents a share - Earnings Preview

Sana Biotechnology

07/05/2022 03:06

* Sana Biotechnology Inc  SANA.OQ   SANA.O  is expected
to show no
change in quarterly revenue when it reports  results on May 9
(estimated). 
    * ​Refinitiv's mean analyst estimate for Sana Biotechnology
Inc is
for a loss of 47 cents per share. For the same quarter last
year, the company reported a loss of 45 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sana
Biotechnology Inc is $17​, above​ its last closing price
of $6.38. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021              -0.55      -0.60     Missed  -8.1
 Sep. 30 2021  -0.46       -0.49      -0.46     Beat    6.8
 Jun. 30 2021  -0.44       -0.45      -0.32     Beat    28.9​
 Mar. 31 2021  -0.57       -0.58      -0.45     Beat    22.4
 ​​Dec.        -0.41       -0.41      -2.98     Missed  -626.8
 31 2020                                                
                                                        ​
 This summary was machine generated May 7 at 02:06 GMT.  All
figures in US dollars  unless otherwise stated